Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Tepper

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmacology Research & Perspectives|December 16, 2014
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonistSumner H Burstein, Mark A Tepper
Cells|July 26, 2024
A Novel PDE10A Inhibitor for Tourette Syndrome and Other Movement DisordersRandall D Marshall, Frank S Menniti, Mark A Tepper
Bioorganic & Medicinal Chemistry|May 27, 2014
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activityMark A Tepper, Robert B Zurier, Sumner H Burstein
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 26, 2004
Formation of human IFN-beta complex with the soluble type I interferon receptor IFNAR-2 leads to enhanced IFN stability, pharmacokinetics, and antitumor activity in xenografted SCID miceSean D McKenna, Kristin Vergilis, Antonio R N Arulanandam, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 11, 2020
Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosisAbdullah A Tarique, Tama Evron, George Zhang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmacology Research & Perspectives|December 16, 2014
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonistSumner H Burstein, Mark A Tepper
Cells|July 26, 2024
A Novel PDE10A Inhibitor for Tourette Syndrome and Other Movement DisordersRandall D Marshall, Frank S Menniti, Mark A Tepper
Bioorganic & Medicinal Chemistry|May 27, 2014
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activityMark A Tepper, Robert B Zurier, Sumner H Burstein
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 26, 2004
Formation of human IFN-beta complex with the soluble type I interferon receptor IFNAR-2 leads to enhanced IFN stability, pharmacokinetics, and antitumor activity in xenografted SCID miceSean D McKenna, Kristin Vergilis, Antonio R N Arulanandam, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 11, 2020
Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosisAbdullah A Tarique, Tama Evron, George Zhang, et al.
Pageof 1